The Opposition

Researchers Wait For Federal Guidelines Two reports, one from each side of the Atlantic Ocean, conclude that research on xenotransplantation-the transfer of organs, tissues, or cells from animals to humans-should be pursued because the potential benefits of the practice outweigh its possible risks. But scientists in the United States are frustrated by the Public Health Service's slow pace in issuing federal guidelines for the research. CAUTIOUS STEPS: Xenotransplantation pioneer Suzanne Ilst

Written byRobert Finn
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Researchers Wait For Federal Guidelines Two reports, one from each side of the Atlantic Ocean, conclude that research on xenotransplantation-the transfer of organs, tissues, or cells from animals to humans-should be pursued because the potential benefits of the practice outweigh its possible risks. But scientists in the United States are frustrated by the Public Health Service's slow pace in issuing federal guidelines for the research.


CAUTIOUS STEPS: Xenotransplantation pioneer Suzanne Ilstad says scientists must proceed carefully.
Meanwhile, some critics of xenotransplantation say that not enough attention is being paid to the chance of disease transmission from animals to humans. And animal-welfare activists are concerned that xenotransplantation may provide an entirely new arena for animal exploitation.

The two reports come from the Institute of Medicine (IOM) in the U.S. and the Nuffield Council on Bioethics in the United Kingdom. IOM, a private, nonprofit organization that provides health policy advice under a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies